Wordt geladen...
Revisiting pars plana vitrectomy in the primary treatment of diabetic macular edema in the era of pharmacological treatment
Diabetic macular edema (DME) is the most common cause of moderate visual loss in diabetic patients. The current treatment of choice for center-involved DME is anti-vascular endothelial growth factor (VEGF) treatment. Most patients that undergo pharmacological inhibition with anti-VEGF agents need mu...
Bewaard in:
| Gepubliceerd in: | Taiwan J Ophthalmol |
|---|---|
| Hoofdauteurs: | , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Wolters Kluwer - Medknow
2019
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6947753/ https://ncbi.nlm.nih.gov/pubmed/31942427 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/tjo.tjo_61_19 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|